INS and diabetic retinopathy: Our analysis identified only 12 “diabetic retinopathy” events; TZP was associated with an increased risk of “diabetic retinopathy” compared to all other drug but with a consistently lower risk vs. GLP-1RA and insulin use, which could represent a proxy for more advanced stages of disease.